Thomas Leggett
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-07–present
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | $496,375 | $1,830,375 |
| 2024 | Stoke Therapeutics, Inc. (STOK) | Chief Financial Officer | $309,470 | $4,520,386 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.